These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11750350)

  • 41. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
    Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
    Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of abbreviated AUC of cyclosporine in renal allograft recipients in a Pakistani population.
    Zafar MN; Abbas K; Naqvi A; Rizvi A
    Transplant Proc; 1999 Dec; 31(8):3304. PubMed ID: 10616486
    [No Abstract]   [Full Text] [Related]  

  • 43. Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant Recipients.
    Cortinovis M; Gotti E; Trillini M; Carrara F; Gaspari F; Ruggenenti P; Remuzzi G; Perico N
    Nephron; 2017; 135(3):173-180. PubMed ID: 27941326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of neoral kinetics in adult renal transplantation treated with diltiazem.
    Mezzano S; Flores C; Ardiles L; Foradori A; Elberg A
    Transplant Proc; 1998 Aug; 30(5):1660-2. PubMed ID: 9723232
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of different sampling times for best prediction of cyclosporine area under the curve in renal transplant recipients.
    Sud K; Singh B; Kohli HS; Jha V; Gupta KL; Sakhuja V
    Transplant Proc; 2002 Dec; 34(8):3168-70. PubMed ID: 12493408
    [No Abstract]   [Full Text] [Related]  

  • 46. Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients.
    Hoyer PF; Boekenkamp A; Vester U; Offner G; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2259-61. PubMed ID: 8769218
    [No Abstract]   [Full Text] [Related]  

  • 47. Predictive value of cyclosporine blood levels during the absorption phase to estimate the area under the curve in stable renal transplant patients.
    Sabaté I; Calzada P; Gil-Vernet S; Fulladosa X; Baró S; González C; Castro MJ; Castelao AM; Grinyó JM
    Transplant Proc; 2002 Feb; 34(1):140-1. PubMed ID: 11959224
    [No Abstract]   [Full Text] [Related]  

  • 48. Conversion from Sandimmune to Neoral in renal transplant: functional histopathological, and pharmacokinetic changes.
    Roessler E; Herrera S; Espinoza M; Ayala A; Reynolds E; González F; Espinoza O; Undurraga A; Muñoz R; Arcos O; Galaz G
    Transplant Proc; 1998 Aug; 30(5):1756-7. PubMed ID: 9723268
    [No Abstract]   [Full Text] [Related]  

  • 49. Evolution of the therapeutic drug monitoring of cyclosporine.
    Citterio F
    Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-hour postdose concentration: a reliable marker for cyclosporine exposure in adolescents with stable renal transplants.
    John U; Ullrich S; Roskos M; Misselwitz J
    Transplant Proc; 2005 Apr; 37(3):1608-11. PubMed ID: 15866686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic drug monitoring of cyclosporine.
    Midtvedt K
    Transplant Proc; 2004 Mar; 36(2 Suppl):430S-433S. PubMed ID: 15041380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of mean relative bioavailability of cyclosporine Sandimmune and Neoral using NONMEM in renal transplant recipients.
    Lee KL; Lee KT; Chung HM; Lin YP
    Transplant Proc; 1998 Nov; 30(7):3526-9. PubMed ID: 9838545
    [No Abstract]   [Full Text] [Related]  

  • 53. Safety and efficacy of conversion from once daily Sandimmun to twice daily Neoral cyclosporine in renal allograft recipients.
    Vathsala A; Lee WT; Lu YM; Woo KT
    Transplant Proc; 1998 Aug; 30(5):1746-8. PubMed ID: 9723264
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetic study of twice vs thrice daily dosing of Sandimmun Neoral in pediatric renal transplant patients.
    Papachristou F; Gakis D; Sotiriou I; Liatsis I; Takoudas D; Antoniadis A
    Transplant Proc; 1998 Aug; 30(5):1988-90. PubMed ID: 9723363
    [No Abstract]   [Full Text] [Related]  

  • 55. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Area under the curve of Neoral and chronic use of mycophenolate mofetil.
    Rial M; Guardia O; Greco G; Argento J; Casadei D
    Transplant Proc; 1998 Jun; 30(4):1195-6. PubMed ID: 9636484
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical benefit of monitoring cyclosporine C2 and C4 in long-term liver transplant recipients.
    Barakat O; Peaston R; Rai R; Talbot D; Manas D
    Transplant Proc; 2002 Aug; 34(5):1535-7. PubMed ID: 12176472
    [No Abstract]   [Full Text] [Related]  

  • 58. Neoral C-2 monitoring in cardiac transplant patients.
    Cooney GF; Johnston A
    Transplant Proc; 2001; 33(1-2):1572-5. PubMed ID: 11267425
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of orange and tangerine juice on cyclosporine levels in renal transplant recipients.
    Sorkhi H; Oliaei F; Moghadamnia AA; Pouramin M; Firoozjahi AR
    Transplant Proc; 2007 May; 39(4):1228-30. PubMed ID: 17524940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced variability of neoral pharmacokinetic studies in pediatric renal transplantation.
    Meier-Kriesche HU; Swinford R; Kahan BD; Brannan P; Portman RJ
    Pediatr Nephrol; 2000 Nov; 15(1-2):2-6. PubMed ID: 11095000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.